1 |
|
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction/
|
French, J. K
|
C. V. Mosby Co
|
2003
|
|
|
2 |
|
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies/
|
Spinler, S. A
|
C. V. Mosby Co
|
2003
|
|
|
3 |
|
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions/
|
Best, P. J
|
C. V. Mosby Co
|
2003
|
|
|
4 |
|
Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study/
|
Ziakas, A. A
|
C. V. Mosby Co
|
2003
|
|
|
5 |
|
Safety profile of transdermal testosterone therapy in women/
|
Shifren, J. L
|
C.V. Mosby Co
|
1900
|
|
|
6 |
|
Sample size calculations in surgery: Are they done correctly?/
|
Maggard, M. A
|
C. V. Mosby Co
|
2003
|
|
|
7 |
|
SAOG information sheet/
|
|
C.V. Mosby Co
|
1900
|
|
|
8 |
|
Sarpogrelate treatment reduces restenosis after coronary stenting/
|
Fujita, M
|
C. V. Mosby Co
|
2003
|
|
|
9 |
|
Screening for early detection of cardiovascular disease in asymptomatic individuals/
|
Cohn, J. N
|
C. V. Mosby Co
|
2003
|
|
|
10 |
|
Screening for fetal well-being in a high-risk pregnant population comparing the nonstress test with umbilical artery Doppler velocimetry: A randomized controlled clinical trial/
|
Williams, K. P
|
C.V. Mosby Co
|
1900
|
|
|
11 |
|
Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization/
|
Singh, Bhuvanesh
|
C. V. Mosby Co
|
2001
|
|
|
12 |
|
Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study/
|
Jensen, D. M
|
C.V. Mosby Co
|
1900
|
|
|
13 |
|
Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure/
|
Baker, D. W
|
C. V. Mosby Co
|
2003
|
|
|
14 |
|
Screening for postpartum depression in an inner-city population/
|
Morris-Rush, J. K
|
C.V. Mosby Co
|
1900
|
|
|
15 |
|
Screening for structural heart disease: time to stop listening and start looking
|
Alexander, J. H
|
C. V. Mosby Co
|
2003
|
|
|
16 |
|
Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis/
|
Makrydimas, G
|
C.V. Mosby Co
|
1900
|
|
|
17 |
|
Secondary Prevention and Rehabilitation - Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease/
|
Garg, Rekha
|
C. V. Mosby Co
|
2000
|
|
|
18 |
|
Selected manuscripts from the 2003 CREOG AND APGO annual meeting/
|
|
C.V. Mosby Co
|
1900
|
|
|
19 |
|
Selective activation of PPARg inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator/
|
Farrow, B
|
C. V. Mosby Co
|
2003
|
|
|
20 |
|
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program/
|
Weir, M. R
|
C. V. Mosby Co
|
2003
|
|
|